WORLDWIDE POSTMARKETING DRUG SURVEILLANCE

被引：0
|
作者：
VENULET, J
机构：
来源：
REVUE DE MEDECINE INTERNE | 1986年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：52 / 56
页数：5
相关论文
共 50 条
  • [1] POSTMARKETING DRUG SURVEILLANCE
    BORDEN, EK
    GARDNER, JS
    WESTLAND, MM
    GARDNER, SD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 251 (06): : 729 - 729
  • [2] POSTMARKETING DRUG SURVEILLANCE
    FELDMANN, EG
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (12) : R1 - R1
  • [3] THE IMPORTANCE OF POSTMARKETING DRUG SURVEILLANCE
    SMART, AJ
    WALTERS, L
    [J]. SOUTH AFRICAN MEDICAL JOURNAL, 1992, 82 (06): : 383 - 384
  • [4] Postmarketing surveillance for drug abuse
    Arfken, CL
    Cicero, TJ
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2003, 70 (03) : S97 - S105
  • [5] Postmarketing surveillance for drug safety
    Holden, WL
    Scarazzini, LJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (05) : 503 - 503
  • [6] POSTMARKETING DRUG SURVEILLANCE STUDIES
    FAICH, GA
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (05) : 597 - 597
  • [7] Using drug courts for drug postmarketing surveillance
    Griffin, O. Hayden, III
    Woodward, Vanessa H.
    [J]. DRUGS AND ALCOHOL TODAY, 2016, 16 (02) : 165 - 175
  • [8] Postmarketing drug surveillance and death by committee
    Lyles, Alan
    [J]. CLINICAL THERAPEUTICS, 2006, 28 (06) : 962 - 963
  • [9] Postmarketing surveillance for drug safety - Reply
    Griffin, MR
    Stein, CM
    Ray, WA
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (05) : 504 - 505
  • [10] The role of databases in drug postmarketing surveillance
    Rodriguez, EM
    Staffa, JA
    Graham, DJ
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2001, 10 (05) : 407 - 410
12345